McDougall Comments on Mammography on the Huffington Post

Note: this content originally appeared in our December 2009 newsletter. More up-to-date research may be available, but the message is still the same!

ACS Chief Sends Mixed Messages on Mammography

John McDougall, MD
Posted December 7, 2009

Dr. Otis Brawley, Chief Medical Officer of the American Cancer Society, voiced strong support for annual mammography for women beginning at age 40 in an Op-Ed piece published November 20, 2009, in newspapers nationwide. This position is in sharp contrast to his statement about mammography made in the New York Times on Wednesday, October 21, 2009. On that day he told women We don’t want people to panic, but I’m admitting that American medicine has overpromised when it comes to screening. The advantages to screening have been exaggerated.” Dr. Brawley has known about the questionable benefits of screening for more than a decade. Regarding mammography

Print Article

Recommended Articles

The Real Coconut Oil Miracle: How a High-Fat, High-Calorie Condiment Became a “Superfood”

Jeff Novick, MS, RDN: The real coconut oil miracle has nothing to do with any magical healing or nutritional properties in coconut oil—it’s how a high-fat, high-calorie condiment was turned into a superfood.

Mary's Mini-McDougall Diet® - Answers to Common Questions

Many are interested in our simplified version of the McDougall diet which often creates much interest and many questions. Mary’s Mini-McDougall Diet® is offered as a way to ease the learning curve for those just starting our program and to increase the efficiency of the regular McDougall diet by simplifying food choices. Mary's Mini-McDougall Diet® is based on simplicity and monotony. It can help to lose weight and/or reset taste buds and get back "on the wagon" to following the basic McD

Cholesterol When and How to Treat It

By John McDougall, MD Elevated cholesterol is one of the most common health worries among people of Western cultures. One reason for this heightened awareness is the sale of a class of powerful and expensive cholesterol lowering agents, known as HMG-CoA reductase inhibitors and commonly called “statins.” They are advertised to where they are now among the most commonly prescribed medications. Pharmaceutical companies don't want you to know about this risk factor for heart disease. They ne